IGM Biosciences Inc
NASDAQ:IGMS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
6.28
17.83
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
IGM Biosciences Inc
Wall Street
Price Targets
IGMS Price Targets Summary
IGM Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
IGMS
is 20.12 USD
with a low forecast of 9.09 USD and a high forecast of 50.4 USD.
IGMS Last Price Targets
IGM Biosciences Inc
The latest public price target was made on Oct 1, 2024 by
Brian Abrahams
from
RBC Capital
,
who expects
IGMS
stock to
rise by 166%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Brian Abrahams
RBC Capital
|
17
USD
Upside 166% |
2 months ago
Oct 1, 2024
|
IGM Biosciences price target lowered to $17 from $20 at RBC Capital
TheFly
|
Asthika Goonewardene
Truist Financial
|
12
USD
Upside 88% |
2 months ago
Oct 1, 2024
|
IGM Biosciences downgraded to Hold from Buy at Truist
TheFly
|
Stephen Willey
Stifel Nicolaus
|
25
USD
Upside 291% |
2 months ago
Oct 1, 2024
|
Stifel Reiterates Buy Rating on IGM Biosciences (IGMS)
StreetInsider
|
Robert Driscoll
Wedbush
|
25
USD
Upside 291% |
4 months ago
Aug 15, 2024
|
IGM Biosciences price target raised to $25 from $20 at Wedbush
TheFly
|
Michael Ulz
Morgan Stanley
|
12
USD
Upside 88% |
4 months ago
Aug 14, 2024
|
Morgan Stanley Reiterates Overweight Rating on IGM Biosciences (IGMS)
StreetInsider
|
|
Brian Abrahams
RBC Capital
|
20
USD
Upside 213% |
7 months ago
May 9, 2024
|
IGM Biosciences (IGMS) PT Lowered to $20 at RBC Capital
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IGMS's stock price target?
Price Target
20.12
USD
According to Wall Street analysts, the average 1-year price target for
IGMS
is 20.12 USD
with a low forecast of 9.09 USD and a high forecast of 50.4 USD.
What is IGM Biosciences Inc's Revenue forecast?
Projected CAGR
77%
The
compound annual growth rate
of IGM Biosciences Inc's revenue for the next 4 years is
77%.
You don't have any saved screeners yet
